Identification of influenza A pandemic (H1N1) 2009 variants during the first 2009 influenza outbreak in Mexico City

Journal of Clinical Virology

Volumn 48, Issue 1, 2010, Pages 36-39

  Zepeda, Hector M ^a   Perea Araujo, Lizbeth ^a   Zarate Segura, Paola B ^a   Vázquez Pérez, Joel A ^a   Miliar García, Ángel ^a   Garibay Orijel, Claudio ^a   Domínguez López, Aarón ^a   Badillo Corona, Jesús A ^a   López Orduña, Eduardo ^b   García González, Octavio P ^c   Villaseñor Ruíz, Ignacio ^d   Ahued Ortega, Armando ^d   Aguilar Faisal, Leopoldo ^a   Bravo, Jorge ^a   Lara Padilla, Eleazar ^a   García Cavazos, Ricardo J ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b Amplibio   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d SECRETARÍA DE SALUD   (Mexico)

Author keywords

Influenza A pandemic (H1N1) 2009

Indexed keywords

HEMAGGLUTININ; SIALIDASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL RESISTANCE; ARTICLE; BIOLOGICAL MONITORING; CHILD; CLINICAL STUDY; DIAGNOSTIC PROCEDURE; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; INFANT; INFLUENZA; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MEXICO; NUCLEOTIDE SEQUENCE; PANDEMIC; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEQUENCE ANALYSIS; SEX DIFFERENCE; VIRULENCE; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; GENETIC VARIATION; GEOGRAPHY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MEXICO; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEURAMINIDASE; RNA, VIRAL;

EID: 77950690163     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.02.008     Document Type: Article

References (25)

1. Olmos-Tomasini C., Gandarilla-Carrillo L.R., Scherer-Ibarra A., Ferreyra-Cuevas V., Morán-Ugarte M., and Romero-Vázquez L.E. Influenza A(H1N1) controlled, official report of the Mexican Health Secretariat. Mexico Sano 2 special number (2009) 1-32
2. Mexican Health, and Secretariat. The influenza A(H1N1) in Mexico City. Official report (2009). http://wwwdgepisaludgobmx/pandemia/influenzahtm
3. World Health Organization. Pandemic (H1N1) 2009 - update 68. http://www.who.int/csr/don/2009_10_02/en/index.html.
4. Shinde V., Bridges C.B., Uyeki T.M., Shu B., Balish A., Xu X., et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360 (2009) 2616-2625
5. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459 (2009) 1122-1125
6. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science May (2009)
7. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360 (2009) 2605-2615
8. Fraser C., Donnelly C.A., Cauchemez S., et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324 5934 (2009) 1557-1561
9. Ward C.L., Dempsey M.H., Ring C.J., Hanage W.P., Van Kerkhove M.D., Hollingsworth T.D., et al. Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Virol 29 (2004) 179-188
10. www.rki.de/cln_091/nn_200120/DE/Content/InfAZ/I/Influenza/IPV/Schweinegr ippePCR.html
11. World Health Organization. Sequencing primers and protocol. 12 May 2009.
12. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22 (1994) 4673-4680
13. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24 (2007) 1596-1599
14. World Health Organization. Wkly Epidemiol Rec 84 26 (2009) 261-268
15. World Helath Organization. Cronology of influenza A (H1N1) (2009), Regional Office for South East Asia. http://www.searo.who.int/LinkFiles/Influenza_A(H1N1)_Chronology_of_Influ enza_A(H1N1).pdf
16. Maurer-Stroh S., Ma J., Lee R.T., Sirota F.L., and Eisenhaber F. Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. Biol Direct 4 (2009) 18
17. Cruz-Pacheco G., Duran L., Esteva L., Minzoni A.A., Lopez-Cervantes M., Panayotaros P., et al. Modeling of the influenza A(H1N1)v outbreak in Mexico City, April-May 2009, with control sanitary measures. Euro Surveill 14 (2009) 19254
18. Anderson R.M., and May R.M. Population biology of infectious diseases: Part I. Nature 280 (1979) 361-367
19. May R.M., and Anderson R.M. Population biology of infectious diseases: Part II. Nature 280 (1979) 455-461
20. Daily inform of the national and international situation. Influenza A/H1N1. Ministry of Health and Public Politics, Spain. http://www.msc.es/servCiudadanos/alertas/informesGripeA/090707.htm.
21. Mermel L.A. Swine-origin influenza virus in young age groups. Lancet 373 June (9681) (2009) 2108-2109
22. Glaser L., Stevens J., Zamarin D., Wilson I., Garcia-Sastre A., Tumpey T., et al. A Single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 19 (2005) 11533-11536
23. Neumann G., Noda T., and Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459 (2009) 931-939
24. Hauge S.H., Dudman S., Borgen K., Lackenby A., and Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1). Emerg Infect Dis 15 February (2009) 155-162
25. Monto A.S., McKimm-Breschkin J.L., Macken C., Hampson A.W., Hay A., Klimov A., et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50 (2006) 2395-2402